Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, ...

We went in search of the region’s best pastrami on rye with a famous — and very opinionated — New York deli expert.

Q3 2025 Earnings Call October 21, 2025 9:00 AM EDTCompany ParticipantsChinmay Trivedi - Senior Vice President of Investor ...

The drone market is basically a royal court where one brand wears the tiny crown. But hiding in the budget broom closet, we found the Potensic ATOM 2, a plucky 249-gram rebel. It delivers ...

An international team led by researchers at MPI-CPfS used irradiation with extremely high-energy electrons to controllably ...

A size V stimulus in a 10-2 visual field test in advanced glaucoma can be more useful than a size III stimulus and may have ...

The weak spot, known as the South Atlantic Anomaly, was identified in the 19th century and expanded in recent years.

If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent to our User Agreement and agree that your clicks, ...

LAS VEGAS — Las Vegas Raiders kicker Daniel Carlson lined up for a 54-yard field-goal try with the game on the line Sunday at Allegiant Stadium. The snap was good. The hold was good. Then Chicago ...

Doctors and life-science companies are looking for alternative approaches to the treatment of type 1 diabetes (T1D) ...

Drivers with more advanced glaucomatous visual field defects may show poorer vehicle handling and avoid heavy traffic, night driving.

This comprehensive presentation examines complex retinal disease management using sequential anti-VEGF therapies, supported ...